#COVID-19 Impacts On Self-injection Devices Market | Explore Tumblr posts and blogs

mordorintelligencemarketresearch · 22 days ago

Text

The Disposable Syringes Industry: A Critical Component of Modern Healthcare

The disposable syringes industry has become a cornerstone of modern healthcare, offering a safe, sterile, and convenient solution for administering medications and collecting biological samples. With the increasing demand for infection control, vaccination programs, and advancements in medical treatments, disposable syringes have emerged as an essential tool for healthcare providers worldwide. Their single-use nature reduces the risk of cross-contamination and ensures patient safety, making them indispensable in hospitals, clinics, and home healthcare settings.

The disposable syringes market is estimated to be valued at USD 15.77 billion in 2024 and is expected to expand to USD 24.86 billion by 2029, with a compound annual growth rate (CAGR) of 9.53% during the forecast period of 2024 to 2029..

Importance of Disposable Syringes in Healthcare

Disposable syringes are pre-sterilized, single-use medical devices designed to deliver medications, vaccines, or fluids into the body or withdraw blood and other fluids for diagnostic purposes. They have largely replaced reusable syringes due to their safety and convenience. Key advantages include:

Infection Prevention: Single-use syringes eliminate the risk of transmitting bloodborne infections such as HIV, hepatitis B, and hepatitis C.

Ease of Use: Pre-sterilized and ready to use, disposable syringes save time and effort in healthcare settings.

Cost-Effectiveness: While reusable syringes require cleaning, sterilization, and maintenance, disposable syringes reduce these associated costs.

Wide Applicability: Used in a variety of settings, including hospitals, clinics, research laboratories, and for at-home care.

The industry has witnessed tremendous growth as healthcare providers and regulatory agencies emphasize safety and hygiene, especially in the wake of global health crises like the COVID-19 pandemic.

Key Drivers of Growth in the Disposable Syringes Industry

1. Rising Demand for Vaccination Programs

Mass immunization campaigns against diseases such as COVID-19, influenza, measles, and polio have significantly boosted the demand for disposable syringes. Governments and international organizations have prioritized the use of safe injection practices, driving the widespread adoption of disposable syringes.

2. Increasing Prevalence of Chronic Diseases

Chronic conditions such as diabetes, cardiovascular diseases, and autoimmune disorders often require regular medication administration through injections. The growing number of patients with these conditions has led to higher demand for disposable syringes for both clinical and at-home use.

3. Enhanced Focus on Infection Control

The global emphasis on infection prevention, particularly in healthcare settings, has underscored the importance of disposable syringes. Regulatory bodies and healthcare organizations advocate for their use to reduce the risk of healthcare-associated infections (HAIs).

4. Expansion of Point-of-Care and Home Healthcare

The rise of point-of-care diagnostics and home-based healthcare services has further propelled the demand for disposable syringes. Patients with chronic illnesses or those requiring long-term care often use disposable syringes for self-administration of medications, ensuring convenience and safety.

5. Technological Advancements in Syringe Design

Innovations in syringe design, such as auto-disable (AD) syringes and safety syringes, have added value to the industry by enhancing user safety and reducing the risk of needle-stick injuries. These advancements align with global healthcare trends prioritizing safety and sustainability.

Challenges Facing the Disposable Syringes Industry

1. Environmental Impact

The single-use nature of disposable syringes contributes to medical waste, posing environmental challenges. Improper disposal can lead to contamination and harm to ecosystems, prompting the need for sustainable waste management solutions.

2. Fluctuating Raw Material Costs

Disposable syringes are primarily made of plastic, and fluctuations in the prices of raw materials such as polypropylene can impact production costs. Manufacturers often face challenges in maintaining affordability while ensuring quality.

3. Regulatory Compliance

The production and distribution of disposable syringes must adhere to strict regulatory standards for safety, quality, and sterilization. Navigating these regulations can be time-consuming and costly, particularly for smaller manufacturers.

4. Supply Chain Disruptions

Global supply chain disruptions, such as those experienced during the COVID-19 pandemic, can affect the availability of raw materials and the timely delivery of syringes. This poses a challenge for meeting surges in demand during health crises.

5. Competition from Alternative Delivery Methods

While disposable syringes remain a dominant choice, alternative drug delivery methods, such as transdermal patches, oral medications, and needle-free injectors, are gaining traction. These innovations present competition and may influence the market dynamics over time.

Innovations and Emerging Trends in the Disposable Syringes Industry

1. Adoption of Safety Syringes

Safety syringes, equipped with mechanisms to prevent needle-stick injuries, are becoming increasingly popular. These include retractable syringes and those with protective shields to enhance user and patient safety.

2. Growth of Auto-Disable Syringes

Auto-disable syringes, designed for single-use with a mechanism that disables the syringe after injection, are in high demand. These are particularly favored in vaccination programs in low- and middle-income countries to prevent reuse and ensure safe disposal.

3. Eco-Friendly Solutions

To address environmental concerns, manufacturers are exploring biodegradable materials and recycling programs for disposable syringes. Innovations in sustainable production processes aim to reduce the carbon footprint of syringe manufacturing.

4. Integration with Smart Technology

Smart syringes equipped with digital tracking and monitoring capabilities are emerging in the healthcare landscape. These devices help ensure accurate dosage and provide data for patient records, improving treatment outcomes.

5. Regional Manufacturing Hubs

To address supply chain challenges, companies are establishing regional manufacturing hubs to meet local demand efficiently. This trend is particularly evident in emerging markets, where healthcare infrastructure is expanding rapidly.

The Role of Disposable Syringes During Global Health Crises

The COVID-19 pandemic highlighted the critical importance of disposable syringes in combating global health emergencies. Mass vaccination efforts required billions of syringes, prompting rapid production scale-ups and international collaborations. The pandemic also underscored the need for resilient supply chains and sustainable practices in the industry.

Conclusion

The disposable syringes industry is a vital component of the global healthcare system, enabling safe and efficient administration of medications and vaccines. Driven by rising healthcare needs, advancements in technology, and increased focus on infection control, the industry continues to expand and innovate.

While challenges such as environmental impact and regulatory compliance remain, the adoption of eco-friendly solutions, safety-enhancing designs, and smart technologies are reshaping the industry’s future. Disposable syringes will remain indispensable in healthcare, playing a critical role in improving patient outcomes, supporting public health initiatives, and addressing global health challenges. As the world navigates evolving healthcare demands, the disposable syringes industry is poised to make significant contributions to the well-being of communities worldwide. For a detailed overview and more insights, you can refer to the full market research report by Mordor Intelligence: https://www.mordorintelligence.com/industry-reports/disposable-syringes-market

#Disposable Syringes Market #Disposable Syringes Market Size #Disposable Syringes Market Share #Disposable Syringes Market Analysis #Disposable Syringes Market Report

0 notes

blog-site-for-market-research · 10 months ago

Text

Tendinitis Treatment Market Share: Analyzing Size and Growth Trends

Market Overview –

During the projected period of 2023–2032, the market for tendinitis treatments is expected to grow at a 3.7% CAGR to reach USD 263.95 billion by 2032.

The tendinitis treatment market is growing steadily, driven by the increasing demand for effective tendinitis therapy options. As more individuals experience tendon inflammation and related injuries, there's a heightened focus on innovative therapies to alleviate pain and promote healing. The market for tendinitis therapy continues to evolve, offering patients various treatment modalities for improved outcomes.

The tendinitis treatment market focuses on providing solutions for a common musculoskeletal condition characterized by inflammation or irritation of a tendon. Tendinitis can affect various parts of the body, including the shoulders, elbows, wrists, knees, and heels, leading to pain, stiffness, and limited movement. This market encompasses a range of treatment options, including medications, physical therapy, braces, and in severe cases, surgery.

One of the primary drivers of the tendinitis treatment market is the increasing incidence of tendinitis-related injuries, attributed to factors such as overuse, repetitive motion, poor ergonomics, aging, and sports activities. As the population ages and lifestyles become more sedentary, the prevalence of tendinitis is expected to rise, driving demand for effective treatment modalities.

Moreover, advancements in medical technology and treatment approaches have expanded the options available for managing tendinitis. Innovative therapies such as extracorporeal shockwave therapy (ESWT), platelet-rich plasma (PRP) injections, and regenerative medicine techniques offer promising alternatives to traditional treatments, providing patients with more options for pain relief and faster recovery.

The COVID-19 pandemic has impacted the tendinitis treatment market, with disruptions in healthcare services, delayed diagnoses, and changes in patient behavior. However, the pandemic has also highlighted the importance of self-care and home-based treatments, leading to increased interest in home exercises, ergonomic modifications, and telemedicine consultations for managing tendinitis symptoms.

Despite challenges such as limited reimbursement for certain treatments and variability in treatment outcomes, the tendinitis treatment market is expected to grow as awareness about the condition increases and as research efforts continue to improve treatment efficacy and patient outcomes. With ongoing innovation and collaboration among healthcare providers, researchers, and industry stakeholders, the tendinitis treatment market holds promise for addressing the needs of patients with tendinitis in the future.

Segmentation –

The Americas & Europe Tendinitis Treatment market is segmented on the basis of type, treatment, and end user.

On the basis of type, the market is segmented into Achilles tendinitis, supraspinatus tendinitis, tennis or golfer's elbow, De Quervain's tenosynovitis, and others.

On the basis of treatment, the market is segmented into diagnosis, therapy, shock wave therapy or surgery, medical devices, devices, and others.

Diagnosis is further segmented into physical examination, imaging tests, ultrasound, Magnetic Resonance Imaging (MRI) Scans, and others.

Therapy is further segmented into non-pharmacological and pharmacological therapy. Non-pharmacological therapy includes rest therapy, heat & cold therapy, occupational therapy, physical therapy, and others. Pharmacological therapy includes OTC drugs or pain relievers, corticosteroids injections, platelet-rich plasma (PRP), and others.

Medical devices is further segmented mechanical band, support tape, pre-cut strips, continuous rolls, and others.

On the basis of end user, the market is segmented into hospitals & clinics, medical research centers, academic institutes, and others.

Regional Analysis –

The tendinitis treatment market's regional analysis reveals varying prevalence rates, treatment approaches, and healthcare infrastructures worldwide. North America leads with a high incidence of tendinitis cases and a strong focus on sports medicine and rehabilitation therapies. Europe follows suit, with an emphasis on conservative treatments and physical therapy modalities. In the Asia-Pacific region, increasing sports participation and aging populations contribute to market growth, driving demand for tendinitis treatments. Latin America and Africa show potential for market expansion with improving healthcare access and rising awareness of musculoskeletal conditions. Market players must adapt their treatment options to meet regional preferences and regulatory requirements, considering factors like affordability, accessibility, and cultural influences.

Key Players –

Some of the Tendinitis Treatment Companies are Almatica Pharma, Inc. based in the US, AstraZeneca from the US, Bayer headquartered in Germany, Boehringer Ingelheim Pharmaceuticals, Inc. situated in the US, Merck & Co., Inc. operating out of the US, Pfizer also located in the US, alongside other contributors.

Related Reports –

Steam Autoclave

Diagnostic Imaging

Neonatal Thermoregulation

Immunotherapy Drugs

For more information visit at MarketResearchFuture

#Tendinitis Treatment Market #Tendinitis Treatment Market Size #Tendinitis Treatment Market Share #Tendinitis Treatment Market Growth #Tendinitis Treatment Market Trends

0 notes

marketinganalysis201 · 2 years ago

Text

https://www.marketwatch.com/press-release/self-injection-device-market-size-share-2022-growth-trends-covid-19-impact-analysis-and-forecasts-to-2030-2022-12-13

0 notes

researchblog66 · 2 years ago

Text

Diabetes Care Devices Market Worth $31.9 Billion by 2028 – Exclusive Report by Meticulous Research®

According to a new market research report, titled “Diabetes Care Devices Market by Type [Diabetes Monitoring (CGM, Test Strips, Self-Monitoring Blood Glucose Meters, Lancets, Haemoglobin A1C Testing Kits)], [Insulin Delivery (Syringes, Pens, Pumps, Jet Injectors)] – Global Forecast to 2028” published by Meticulous Research®, the diabetes care devices market is expected to grow at a CAGR of 6.7% from 2021 to reach $31.9 billion by 2028.

Download Free Sample Report Now @ https://www.meticulousresearch.com/download-sample-report/cp_id=3438

As the prevalence of diabetes is increasing globally, self-management of diabetic treatments has become necessary to avoid long-term complications and fatalities. Diabetes care devices play an important role in managing diabetes as they enable patients to record and track their blood glucose levels all day long and administer the insulin doses according to the insulin levels.

The key factors driving the overall diabetes care devices market are the rising obesity cases, unhealthy and sedentary lifestyle, increasing prevalence of diabetes, and development of new insulin delivery systems. However, some limitations of diabetes care devices are their high costs and accessibility in low-middle income countries.

Impact of COVID-19 on Diabetes Care Devices Market

The COVID-19 pandemic has severely impacted the diabetes care devices market. COVID-19 patients had higher blood glucose levels due to the use of steroids for the COVID-19 treatment. In 2020, the increase in the number of individuals suffering from diabetes due to COVID-19 expanded the income of the central participants in the diabetes care division. Many players in the market presented new progressed diabetes care devices and association arrangements for diabetes care devices.

Speak to our Analysts to Understand the Impact of COVID-19 on Your Business: https://www.meticulousresearch.com/speak-to-analyst/cp_id=3438

Diabetes Care Devices Market Overview

The diabetes care devices market is segmented based on type: (diabetes monitoring devices and insulin delivery devices) and geography (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa). The study also evaluates industry competitors and analyzes their market share at a global level.

In 2021, the diabetes monitoring devices segment is estimated to account for the largest share of the overall diabetes care devices market. This is mainly attributed to the increased adoption of test strips and self-monitoring blood glucose meters and increasing demand for continuous glucose monitoring with rising awareness towards the disease in developing countries. Diabetes monitoring devices can be utilized to monitor blood glucose values and help the patient adjust their dietary intake, physical activity, and insulin doses to improve glycemic control on a regular basis.

Diabetes monitoring devices are further segmented into continuous blood glucose monitoring devices, test strips, lancets, self-monitoring blood glucose meters, and hemoglobin A1C testing kits. The test strips segment is expected to dominate the diabetes monitoring devices market in 2021, primarily due to the frequent usage of test strips for both continuous and self-glucose monitoring and is widely used by patients in developing countries.

Moreover, insulin delivery devices also are further segmented into insulin syringes, insulin pens, insulin pumps, and insulin jet injectors. In 2021, the insulin pens segment is expected to dominate the insulin delivery devices market. This can be primarily attributed to its advantages over traditional syringe insulin delivery methods, including improved patient satisfaction and adherence, user-friendly, greater ease of use, superior accuracy for delivering small insulin doses, greater social acceptability, and less reported injection pain. However, insulin pumps are the fastest-growing segment due to the advantages such as predictable insulin delivery, precise delivery of insulin, and reduction of wide fluctuation in blood glucose. It also mimics the normal pancreas’s release of insulin.

Quick Buy – Diabetes Care Devices Market Research Report: https://www.meticulousresearch.com/Checkout/33395503

Geographically, in 2021, North America is estimated to account for the largest share of the global diabetes care devices market, followed by Europe and Asia-Pacific. Factors such as the increasing prevalence of diabetes with the rising need to self-monitor and treat the disease, increasing prevalence of major risk factors of diabetes such as obesity and sedentary lifestyle, increasing geriatric population, and growing government initiatives promoting diabetes care are driving the growth of the diabetes care devices market in North America. However, Asia-Pacific region is expected to grow at the highest CAGR during the forecast period. Growth in this market is expected to be driven by the increasing prevalence of diabetes with the rising need to self-monitor the treatments, increasing prevalence of obesity and sedentary lifestyle, growing geriatric population, and government initiatives promoting diabetes care.

The report also includes an extensive assessment of the key strategic developments of leading market participants in the industry over the past four years. In recent years, the diabetes care devices market has witnessed several new product launches, approvals, agreements, collaborations, partnerships, expansions, and acquisitions. For instance, in May 2021, Medtronic PLC (Ireland) received CE Mark approval for the expanded functionality of its InPen and Guardian 4 sensors. Moreover, in February 2020, Abbott Laboratories (U.S.) partnered with Insulet Corporation (U.S.) to combine its leading continuous glucose monitoring (CGM) technology with Insulet’s Omnipod Horizon Automated Insulin Delivery System.

Some of the key players operating in the global diabetes care devices market are Novo Nordisk A/S (Denmark), Ypsomed AG (Switzerland), Abbott Laboratories (U.S.), Ascensia Diabetes Care Holdings AG (Switzerland), F. Hoffmann-La Roche Ltd (Switzerland), LifeScan IP Holdings, LLC (U.S.), Medtronic PLC (Ireland), Becton, Dickinson and Company (U.S.), Terumo Corporation (Japan), Sanofi AS (France), and DexCom, Inc. (U.S.), among others.

The diabetes care devices market is dominated by Abbott Laboratories (U.S.), Medtronic PLC (Ireland), DexCom, Inc. (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Ascensia Diabetes Care (Switzerland), LifeScan IP Holding, LLC (U.S.), Becton, Dickinson and Company (U.S.), Insulet Corporation (U.S.), Novo Nordisk A/S (Denmark), and Tandem Diabetes Care, Inc. (U.S.). Together, these companies held around 80% share of the global diabetes care devices market in 2020.

To gain more insights into the market with a detailed table of content and figures, click here: https://www.meticulousresearch.com/product/diabetes-care-devices-market-3438

Scope of the Report:

Diabetes Care Devices Market, by Type

Diabetes Monitoring Devices

Insulin Delivery Devices

Diabetes Care Devices Market, by Geography

North America

U.S.

Canada

Europe

Germany

U.K.

France

Italy

Spain

Rest of Europe (RoE)

Asia-Pacific (APAC)

China

Japan

India

Rest of APAC (RoAPAC)

Latin America

Middle East & Africa

Download Free Sample Report Now @ https://www.meticulousresearch.com/download-sample-report/cp_id=3438

1 note · View note

market-insider · 2 years ago

Text

Self-Injection Devices Market 2022 | Cancer Segment Anticipated To Gain Highest Industry Share

The global self-injection devices market size is expected to reach USD 10.8 billion by 2030, according to a new report by Grand View Research, Inc. It is projected to expand at a CAGR of 5.7% from 2022 to 2030. Increasing patient volume and rising prevalence of chronic diseases along with the high adoption of advanced drug delivery systems are factors estimated to surge the demand for self-injection devices.

Prevention of needlestick injury is a primary factor for healthcare professionals and companies to introduce self-injection devices such as autoinjectors. To avoid needlestick injuries to healthcare workers, the U.S., Europe, and other markets mandate the use of safety devices. Several auto-injectors provide the additional benefit of needlestick protection to healthcare professionals. It is expected that in the U.S. about 69,000 injuries can be prevented annually. Numerous auto-injectors have integral and passive safety features that eliminate or reduce the risk of injury.

Gain deeper insights on the market and receive your free copy with TOC now @: Self-injection Devices Market Report

Innovation in the field of New Drug Delivery Systems (NDDDS) has led to the rising demand for self-administered medications. The invention of novel injectable delivery devices such as pre-filled syringes, pen injectors, autoinjectors, and needle-free injectors has made the self-administration of drugs easier and more convenient for patients. The majority of biological drugs are delivered using injections, which include the threat of needlestick injuries. To minimize this issue, pharmaceutical firms are developing self-administered needle-free injectors and patient-friendly medication-device combination products.

The COVID-19 pandemic has altered expectations and perceptions of delivery settings and contributed to a rise in preference for self-administration medication. As this becomes the norm, several manufacturers are inclined to make the patient experience the vital component of drug delivery design. Significantly, the COVID-19 vaccines will increase the demand for injectable devices and the pandemic has also shown the benefit of self-use devices as well as connected devices. Post-pandemic there may be a rise in upcoming innovation in devices and pharma manufacturers will progressively collaborate to use self-injection devices in combination with other digital assets such as apps, phones, and personal computers. Eventually, this will bring the patient into far greater control of their care.

#Self-injection Devices Market Size & Share #Self-injection Devices Market Latest Trends #Self-injection Devices Market Growth Forecast #COVID-19 Impacts On Self-injection Devices Market #Self-injection Devices Market Revenue Value #Global Self-injection Devices Market

0 notes

desaletushki · 2 years ago

Text

Pacemakers Market Size, Share, Trends And Forecast 2030

The global pacemakers market size is anticipated to reach USD 5.94 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a lucrative CAGR of 3.4% from 2022 to 2030. This growth is owing to various factors such as technological advancements and the increasing prevalence of cardiovascular devices. Furthermore, the growing sedentary lifestyle coupled with the rising geriatric population is also anticipated to fuel the market growth during the projected period. During the COVID-19 pandemic, the market experienced a decline in revenues. This is owing to the postponement and cancellation of surgeries. According to the National Center for Biotechnology Information (NCBI), there was around a 73% reduction in de-novo pacemaker implantation during the initial months of the pandemic, which heavily impacted the market.

The increasing prevalence of cardiovascular diseases is a key growth driver for the market. As per the CDC in 2017, CVDs account for about 800,000 deaths in the U.S alone. Moreover, coronary heart disease accounts for the highest number of deaths, followed by stroke and heart failure. As per the British Heart Foundation Centre in 2018, nearly 7.4 million individuals are living with circulatory and heart diseases in the U.K. More than 43,000 individuals under 75 years of age die due to cardiac diseases every year in the U.K. To curb the rising prevalence of CVDs is government bodies and key market players are channelizing revenues to offer a potential treatment. This is anticipated by the influx of advanced products in this market space.

As per the CDC, 2020, more than 15% of U.S. adults are physically inactive that shows the prevalence of adult physical inactivity. Technological developments are quickly renovating the pacemaker market. Key players are focusing on expanding their current portfolio as in January 2020, BIOTRONIK launched an injectable cardiac monitor, BIOMONITOR III in Japan. It is intended to measure irregular heart rhythms with increased clarity. The injectable cardiac monitor also documents the unexplained syncope. Moreover, in November 2021, Abbott revealed the latest data for its Aveir leadless pacemaker for the treatment of patients with abnormal heart rhythms. The data demonstrated that the product if approved would provide various benefits during the treatment of slow heart rhythms.

Browse Full Report: https://www.grandviewresearch.com/industry-analysis/pacemaker-market

Pacemakers Market Report Highlights

The market was valued at USD 4.38 billion in 2021 and is expected to witness a CAGR of 3.4% during the forecast period

The MRI compatible pacemakers segment is expected to witness the highest CAGR from 2022 to 2030 owing to a higher patient preference rate as 75% of the patients with pacemakers are likely to get MRI during their lifetimes

The atrial fibrillation segment held the largest revenue share in 2021 owing to the heightened prevalence of growing with age. As per the National Center for Biotechnology Information, 2020, nearly 6 to 12 million people globally are expected to suffer from atrial fibrillation in the US alone by 2050

The biventricular pacemakers segment is expected to grow fast from 2022 to 2030. It is also known as Cardiac Resynchronization Therapy (CRT). An increase in the prevalence of heart failure is one of the major factors driving the demand for biventricular pacemakers

Key companies are adopting new strategies to attain a competitive edge. Product development, collaborations, partnerships, mergers and acquisitions, and regional expansion are a few of them

Key Companies & Market Share Insights

Key companies undertook various strategic initiatives such as product launches, mergers and acquisitions, and partnerships and collaborations to gain more penetration. For instance, in June 2021, Medtronic launched the Micra AV, a self-contained, miniaturized pacemaker for delivering advanced pacing technology for atrioventricular (AV) block patients through a minimally invasive approach. Some of the prominent players in the pacemakers market include: OSYPKA MEDICAL, Boston Scientific Corporation, Zoll Medical Corporation an Asahi Kasei Group Company, Medtronic, BIOTRONIK SE & Co. KG, MicroPort Scientific Corporation, MEDICO S.R.L., Shree Pacetronix Ltd., Abbott, OSCOR Inc, Lepu Medical Technology(Beijing)Co. Ltd.

Request Free Sample Report: https://www.grandviewresearch.com/industry-analysis/pacemaker-market

#Pacemakers Market Size #Pacemakers Market Share #Pacemakers Market Sales #Pacemakers Market Growth

0 notes

wiseguyreport1222 · 3 years ago

Link

0 notes

itssashasharma · 3 years ago

Text

Inspection Machines Market : Technological advancements in the field of Pharmaceutical and Medical Device

According to the new market research report “Inspection Machines Market by Product (Vision Inspection, Checkweigher, Metal Detector, Software), Type (Manual, Automatic), Packaging Type (Vials, Syringes, Blisters), End User (Pharmaceutical, Medical Device), COVID-19 Impact – Global Forecast to 2025″, published by MarketsandMarkets™, the Inspection machine market is projected to reach USD 871 million by 2025 from USD 671 million in 2020, at a CAGR of 5.4% during the forecast period.

Browse in-depth TOC on “Inspection Machines Market” 134 – Tables 46 – Figures 231 – Pages

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=81453085

The growth of this market is majorly driven as companies are now increasingly adopting inspection systems throughout their production lines due to the growing concerns to the regulatory mandates introduced by the government and regulatory bodies in the healthcare industry to maintain compliance with Good Manufacturing Practices (GMP). Furthermore, the increasing adoption of automated inspection systems in the pharmaceutical and biotechnology industries, growth in the number of product recalls, an increasing number of inspection checkpoints throughout the production line, and technological advancements in inspection systems support the growth of the market. However, the growing demand for used and refurbished inspection systems is expected to restrain this market’s growth to a certain extent. Also, the complexities of introducing inspection machines in a production line may hamper the market’s growth to a certain extent.

Since the beginning of 2020, the majority of the countries worldwide shut down their borders and limited transportation in a bid to contain the coronavirus (COVID-19) outbreak, thus, creating impediments for international trade and transportation. This had disrupted the supply chains for the inspection machines market, temporarily leading to a fall in demand due to uncertainty in the global economy and capital markets.

The software segment is expected to grow at the highest CAGR during the forecast period

Based on product, the inspection machines market is segmented into vision inspection systems, leak detection systems, X-ray inspection systems, combination systems, checkweighers, metal detectors, software, and other inspection systems. The software segment is projected to witness the highest growth in the market during the forecast periods (2020-2025). Growth in this segment is driven mostly by the increasing demand for faster inspection of products in the manufacturing process and minimal human inspection leads to the growth of adopting digital solutions for better imaging and accuracy. Software integrated with such systems is improving the overall process efficiency.

The fully automated machines segment is expected to account for the largest share of the market

Based on type, the market is segmented into fully automated machines, semi-automated machines, and manual machines. The fully automated machines segment accounted for the largest share of the inspection machines market in 2019. The large share of the fully automated machines segment can be attributed to these systems benefits, such as high throughput rate, maximum inspection accuracy, high detection rate, and compliance with high standard regulations compared to the other systems. The real-time defect tracking capability of these systems makes it a choice to avoid re-inspection, and are thus being adopted across various industries.

Syringes segment is expected to grow at the highest rate during the forecast period

Based on application, the inspection machines market is segmented into ampoules & vials, syringes, blister packaging, bottles, and other packaging types. The syringes segment is expected to grow at the highest CAGR during the forecast period, primarily due to the increasing adoption of inspection machines being used to check pre-filled syringes as these syringes are witnessing a surge in adoption for injectable drug delivery and vaccines. Also, the benefits of reduced drug wastage increased product life span, and the easy self-administer of injectable drugs at home are expected to support market growth in this segment.

The pharmaceutical & biotechnology companies end-user segment is expected to account for the largest share of the market

The inspection machines market, by end-user, is segmented into pharmaceutical & biotechnology companies, medical device manufacturers, food processing & packaging companies, and other end-users (nutraceuticals and cosmetic companies). The pharmaceutical & biotechnology companies segment accounted for the largest market share in 2019. Inspection machines are widely used in pharmaceutical & biotechnology companies for quality checks and quality assurance, which is a major factor in driving the market growth. Furthermore, a growing number of pharmaceutical & biotechnology companies are utilizing inspection machines owing to factors such as the increasing compliance to GMP guidelines and the increasing number of inspection checkpoints in the production & packaging lines, stringent government regulations, the increasing need to combat counterfeit pharmaceutical products, product recalls, and the prevention of loss of business revenue due to the deployment of inspection machines.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=81453085

Asia Pacific is expected to account for the highest CAGR for players operating in the market

The Asia Pacific inspection machines market is expected to grow at the highest CAGR from 2020 to 2025. Factors such as the increasing number of regulatory mandates in the healthcare industry to maintain compliance with good manufacturing practices (GMP); the growing number of pharmaceutical & biotechnology manufacturers; significant economic development in emerging markets such as China and India; tremendous growth in the pharmaceutical, food processing & packaging, and medical device industries; and favorable government initiatives to promote the inspection of products in the pharmaceutical & biopharmaceutical industries are expected to drive the growth of this market during the forecast period.

The prominent players in this inspection machines market are Robert Bosch GmbH (Germany), Körber AG (Germany), METTLER-TOLEDO International Inc. (US), ACG Group (India), Cognex Corporation (US), OMRON Corporation (Japan), Teledyne Technologies Incorporated (US), Brevetti CEA SpA (Italy).

Browse Adjacent Markets: Pharmaceuticals Market Research Reports & Consulting

Browse Related Reports:

Pharmaceutical Packaging Equipment Market by Product (Aseptic Packaging, Blister, Strip, Bottle, Tube, Carton, Case Packer, Wrapping Machine, Palletizing, Labeling & Serialization), Type (Tablet, Powder, Cream, Syrup, Aerosol), Region – Global Forecast to 2025

https://www.marketsandmarkets.com/Market-Reports/pharmaceutical-packaging-equipment-market-19845828.html

Fluoroscopy Equipment Market

by Product (Fixed C-Arms, Fluoroscopy Systems (Remote Controlled, Patient Side), Mobile C-arms), and Application (Diagnostic (Cardio, Gastroenterology, Nephrology), Surgical (Ortho, Neuro, Cardio) – Global Forecast to 2025

https://www.marketsandmarkets.com/Market-Reports/fluoroscopy-equipment-market-23056341.html

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the “Growth Engagement Model – GEM”. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write “Attack, avoid and defend” strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, “Knowledge Store” connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact: Mr. Aashish Mehra MarketsandMarkets™ INC. 630 Dundee Road Suite 430 Northbrook, IL 60062 USA: +1-888-600-6441 Email: [email protected] Research Insight: https://www.marketsandmarkets.com/ResearchInsight/inspection-machines-market.asp Visit Our Web Site: https://www.marketsandmarkets.com Content Source: https://www.marketsandmarkets.com/PressReleases/inspection-machines.asp

#Inspection Machines Market

0 notes

palakjain123 · 3 years ago

Text

Global Injection Pen Market Share, Size, Future Outlook, COVID-19 Impact Analysis, Forecast 2021-2027

The global injection pen market is projected to grow at a CAGR of 6.8% during the forecast period (2020-2026). The key factors that drive the growth of the market include the increased demand for modern and self-drug delivery devices for patients across the globe. The ability to self-inject is one of the prominent drivers for the growth of the injection pens market, which encourages its adoption over the forecast period. These injection pens are primarily used for the subcutaneous delivery of the drugs and also for the self-administration of the drugs. Moreover, the rising prevalence of various disorders such as diabetes, arthritis, and hormonal disorders across the globe is also promoting the growth of the market.

Get Report Sample Copy https://www.omrglobal.com/request-sample/injection-pen-market

Further, there has also been a significant shift from the syringes and vial for the drug delivery to the self-injection among the patients, as these novel drug delivery devices are known to be easier and more convenient for the patients to use. The injection pens also leverage the benefit of home care treatment solutions, which again is a major factor accelerating the growth of the injection pen market over the forecast period. Furthermore, the contributions by the key players in the development of more advanced injection pens are also contributing to the market growth, as these are widely preferred by nearly half of the patient pool suffering from diabetes problems.

A Full Report of Global IoT Sensors Market is Available at: https://www.omrglobal.com/industry-reports/injection-pen-market

Segmentation

Global Injection Pen Market by Type

o Reusable

o Disposable

Global Injection Pen Market by Disorder Type

o Autoimmune Disorders

o Hormonal Disorder

o Orphan Diseases

o Others

Company Profiles

· AstraZeneca Plc

· Bayer AG

· Becton, Dickinson & Co.

· Biocorp Production SA

· Copernicus

· Eli Lilly and Co.

· F. Hoffmann-La Roche Ltd.

· Gerresheimer AG

· Haselmeier GmbH

· Merck KGaA

Reasons to Buying From us –

1. We cover more than 15 major industries, further segmented into more than 90 sectors.

2. More than 120 countries are for analysis.

3. Over 100+ paid data sources mined for investigation.

4. Our expert research analysts answer all your questions before and after purchasing your report.

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/injection-pen-market

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

Media Contact: Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: [email protected] Contact no: +91 780-304-0404

0 notes

blueweave8 · 3 years ago

Text

Pen Needles Market by Type, Size, Forecast 2021-2027

A recent study conducted by the strategic consulting and market research firm, BlueWeave Consulting, revealed that the global pen needles market was worth USD 1.1 billion in the year 2020. The data yielded by the study further reveals that the market is estimated to grow at the CAGR of 10.4%, earning revenue of around USD 2.3 billion by the end of 2027.The market is expected to grow as a result of factors such as the growing number of chronic diseases, the increasing geriatric older population, innovative product launches, and the growing demand for minimally invasive procedures around the world.Further contributing to the market growth is the availability of a wide range of cost-effective and high-performance products as well as easy accessibility to these products through retail stores. However, the development of reusable pen needles may hamper the growth of the global pen needles market in the long run. Also, the limited accessibility of pen needles in comparison with traditional syringes has been hampering the market growth.

High Convenience Over Syringes and Vials Favoring the Growth of Pen Needles Market Worldwide

Pen needles are used to deliver injectable medicines into the human body. The convenience offered by pen needles over syringes and vials has made them very popular over the past few decades.It is much more complicated to use syringes and vials, which requires expert supervision.Furthermore, they are rarely prescribed under self-administration.Pen needles, on the other hand, are comparatively much smaller in size, making it easier to inject the medicine or drug.These needles are very sharp and pointed which makes the process of insertion in the body much easier and more painless as compared to syringes and vials. Because of this, the global pen needles market is gaining significant traction.

Increasing Prescription of Insulin Therapy Anticipated to Boost the Global Pen Needles Market

Based on therapies, the global pen needles market is categorized into insulin therapy, growth hormone therapy, glucagon-like peptide-1 therapy, and other therapies. Among diabetic patients, insulin therapy has a very high demand, and it represents a large share of the market in 2020.It is due to the high prevalence of type 1 and type 2 diabetic patients, along with the growing awareness of insulin injections with pen needles.Additionally, the demand for glucagon-like peptide-1 therapy continues to grow as a result of its ability to boost glucose levels instantly.

Global Pen Needles Market - By Length

Based on length, the global pen needles market is classified into 4MM, 5MM, 6MM, 8MM, 10MM, and 12MM. The 8MM needle size has the largest market demand. They are almost used by all types of patients and are specifically suitable for patients suffering from different types of chronic diseases. Furthermore, the demand for the 4MM-sized needle market is also very prominent and is projected to grow at incredible CAGR in the forecast period. As the smallest needle size, 4MM-sized needles are considered the most comfortable because they are painless.

Request to Download Free Sample report @ https://www.blueweaveconsulting.com/report/global-pen-needles-market/report-sample

Global Pen Needles Market - Regional Insights

Geographically, the global pen needles market is segmented into North America, Europe, Asia-Pacific, Latin America, Middle-East & Africa. Among all the regions, North America dominated the global pen needles market in 2020, followed by Europe. The growth of the region is attributable to a strong healthcare system with favorable reimbursement policies, which is also driving the market growth. However, the industry players are now targeting the markets of emerging economies which are still untapped. Therefore, the Asia-Pacific region is projected to witness a high CAGR in the forecast period. The rising awareness and adoption of medical technologies are favoring the growth of the APAC countries.

Impact of COVID-19 on Global Pen Needles Market

The COVID-19 virus outbreak was accompanied by a similar pattern, in which most patients with the virus suffered from chronic diseases.Because of this, the focus on the management and treatment of patients with such conditions who are at higher risks increased.As a result, the demand for pen needles increased, particularly for the geriatric population that is under home care. Furthermore, the demand is expected to increase significantly in the post-COVID-19 period since hospital visits are still at lower rates due to social distancing norms.

Competitive Landscape

The leading market players in the global pen needles market are Owen Mumford Ltd., Becton Dickinson and Company, Novo Nordisk, Allison Medical, Inc., Ypsomed Holding AG, ArtsanaS.p.a, B. Braun Melsungen AG, HTL Strefa S.A., Terumo Corporation, UltiMed Inc., Vogt Medical Vertrieb, Nipro Corporation, Arkray, Ultimed, Hindustan Syringes And Medical Devices, Glucorx, Berpu Medical Technology, AdvaCare Pharma, Trividia Health, and other prominent players.

The key industry players essentially focus on innovating and advancing their products to maintain a competitive edge. They are consistently trying to grab a larger market share by strengthening their distribution channels and making their products more accessible, especially in developing countries that hold great potential.

About Us:

Blueweave Consulting offers a one-stop solution for your market intelligence needs for any service or product. You get well-researched comprehensive reports based on qualitative and quantitative data to put your business plan into action. Your well-informed and timely decisions using our reports avert situations of excessive risks and help you grow your business with optimum risk-return trade-off.

#pen needles market #Pen Needles Market 2021 #Pen Needles Market Size #Pen Needles Market Demand #Pen Needles Market report

0 notes

marketreports-world · 3 years ago

Text

Blood Glucose Test Strip Packaging Market Research Report - Global Forecast Till 2027

The blood glucose test strips are enclosed in high barrier pouches and vails in order to protect their quality from getting deteriorated due to environmental factors such as moisture, bacterial contamination and others. As per the report that has been published by Market Research Future (MRFR), the global blood glucose test strip packaging market is registered to expand steadily in the coming years.

Market Drivers and Restraints:

Increasing demand for blood glucose test strips due to rise in prevalence of diabetes in all the regions of the world and rapid adoption of self-blood glucose testing devices are majorly propelling the expansion of the global blood glucose test strip packaging market. Innovation in the manufacturing process by the incorporation of advanced technology has significantly improved the quality of packaging, which in turn is fueling the growth of the global blood glucose test strip packaging market.

Increasing geriatric population, prevalence of obesity and diabetes and the adoption of flexible packaging solutions are some of the other factors that are driving the global blood glucose test strip packaging market. However, poor healthcare facilities in the underdeveloped regions and lack of awareness are likely to impact negatively on the growth of the global blood glucose test strip packaging market.

Market Segmentation:

The global blood glucose test strip packaging market has been segmented on the basis of product type. Based on product type, the blood glucose test strip packaging market is segmented into plastic vials, aluminum foils and others. The plastic vials segment is sub-segmented into plastic vials with loose desiccant, plastic vials with injected desiccant, plastic vials with other desiccant and plastic vials without desiccant.

Request Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/551

Regional Analysis:

Geographically, the global blood glucose test strip packaging market has been segmented into four major regions such as North America, Europe, Asia Pacific and the Middle East and Africa. Among these, The North America region is projecting dominance over the global blood glucose test strip packaging market owing to the high demand for blood glucose test strips as the prevalence of diabetes is increasing in this region. The blood glucose test strip packaging market in the Europe region is growing at a noteworthy rate due to the high prevalence of diabetes and obesity and high adoption of self-blood glucose testing in this region. Increasing incidences of diabetes in the Middle East region is fueling the growth of the global blood glucose test strip packaging market in this region. Whereas, lack of awareness is likely to hamper the growth of blood glucose test strip packaging market in the Middle East and Africa region during the forecast period.

Industry Updates:

In July 2018, SVAM Packaging Industries Pvt Ltd, an India-based manufacturer of healthcare and food packaging, has partnered with Japanese packaging giant and one of the world's finest technology driven aluminum company, Toyo Aluminum K.K.

In May 2018, Selected lots of Roche's Accu-Chek Aviva and Accu-Check Performa test strips were recalled due to manufacturing and packaging issues that had caused strip error and biased results.

Key Players:

The leading players that are profiled by MRFR in the report on the global blood glucose test strip packaging market are CSP Technologies (the U.S), Sanner (the U.S), Multisorb Technologies (the U.S), Impak Corporation (the U.S), Laminated films & Packaging (LF&P), INC (the U.S), Flow Dry TechnologY, INC. (the U.S), LPS Industries, LLC (the U.S), Roche Diagnostics, Abbott Laboratories, Lifescan, Inc. (A Johnson & Johnson Company), I-Sens, Inc., Trividia Health (Previously Known As Nipro Diagnostics, Inc.), Ascensia Diabetes Care Holdings Ag (Previously Known As Bayer Diabetes Care), Apex Biotechnology Corporation, Agamatrix Inc., Taidoc Technology Corporation, Universal Biosensors, Beijing Yicheng Electronic Co., Ltd., Sannuo Biosensor Inc., Shanghai Microsense Tm Inc., Acon Laboratories, Inc., Allmedicus, National Diagnostic Products, Hmd Biomedical, Yuwell-Jiangsu Yuyue Medical Equipment & Supply Co., Ltd., 77 Elektronika Kft., B. Braun Melsungen Ag and others.

Table Of Content

1 INTRODUCTION

1.1 DEFINITION

1.2 SCOPE OF THE STUDY

1.2.1 RESEARCH OBJECTIVES

1.2.2 ASSUMPTIONS & LIMITATIONS

1.3 Market STRUCTURE

2 RESEARCH METHODOLOGY

2.1 RESEARCH PROCESS

2.2 PRIMARY RESEARCH

2.3 SECONDARY RESEARCH

2.4 FORECAST MODEL

3 REPORT EXCERPT

4 FORECAST INDICATORS

4.1 INTRODUCTION

4.2 GROWTH DRIVERS

4.3 GROWTH BARRIERS

4.4 GROWTH OPPORTUNITIES

4.5 MACROECNOMICAL INDICATORS

5 Market ANALYSIS 6 Global BLOOD GLUCOSE TEST STRIP Market

Browse Detailed TOC with COVID-19 Impact Analysis at: https://www.marketresearchfuture.com/reports/blood-glucose-test-strip-packaging-market-551

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

Related Report:

Contact:

Akash Anand

Market Research Future

+1 646 845 9312

Email: [email protected]

#Blood Glucose Test Strip Packaging Market

0 notes

blueweave01 · 4 years ago

Text

Global Prefilled Syringes Market Exhibiting Prolific Growth: Predicted to Garner USD 9.40 Billion During the Forecast Period (2021- 2027)

A recent study conducted by the strategic consulting and market research firm, BlueWeave Consulting revealed that the global prefilled syringes market was worth USD 5.31 billion in 2020. The study further states that the market is expected to grow at the CAGR of 8.5% during 2021-2027 (forecast period), earning revenue of around USD 9.40 billion by the end of 2027. This growth of the global prefilled syringes market can be attributed to the rise in prevalence of chronic diseases, technological advancements, increase in adoption of self-injecting parenteral devices, and supportive government regulations (especially needlestick legislations). A rise in the number of biologics and biosimilars in the pharmaceuticals industry, as well as increasing awareness of the advantages of prefilled syringes among patients and healthcare professionals, is fueling market expansion.

Prefilled syringes have several advantages over typical vial packaging, including convenience of use. Because prefilled syringes contain the exact dose, they help eliminate dosage blunders. Many pharmaceutical companies overfill vials by up to 25% to ensure that the end user receives the prescribed dose. Overfilling, on the other hand, can result in errors that are almost eliminated with prefilled syringes.

Advancements in prefilled syringes technology Driving the Growth of Prefilled Syringes Market

The advancements in prefilled syringes have increased their ease of use, reduced drug wastage, and considerably improved dosing accuracy. Manufacturers are also developing enhancements in the component materials. For instance, plastic prefilled syringes available in th market offer high heat resistance. Moreover, in comparison to traditional glass syringes, these syringes are less permeable to water and incredibly light. As a result, advancements in prefilled syringes have encouraged operational convenience, which has increased its acceptance globally. Prefilled syringes that have recently been developed eliminate the possibility of providing the wrong dosage regardless of syringe orientation. As a result, technological breakthroughs have aided the development of prefilled syringes, thereby driving the growth of the global prefilled syringes market.

Scarcity of prefilled syringes with integrated safety features hampering market growth

Prefilled syringes improves patient safety by lowering the risk of unintended needlestick injuries and exposure to toxic products that can occur while drawing medicines from vials. There are significant number of needle stick injuries that are associated with the use of bare prefilled syringes as compared to those that have integrated safety systems. Besides this, the limited market presence of prefilled syringes with integrated safety features is due to their expensive and challenging production procedure. Although, it is a matter of concern in the market, however, this trend is expected to change in the upcoming years, as the healthcare industry is laying greater focus on reducing the rate of needlestick injuries, which, will pave the way for the development of prefilled syringes market.

Safety Prefilled Syringes Segment is the largest Type Segment

Based on the product type, the global prefilled syringes market is segmented into conventional prefilled syringes and safety prefillred syringes. Due to an increased demand for patient safety and growing use of disposable devices in hospitals and home care settings, the safety prefilled syringes segment held the largest market share in 2020 and is likely to maintain dominance even during the forecast period. Furthermore, since the risk of contamination associated with disposable devices is low, the safety segment of the global prefilled syringes market is growing substantially.

Glass Prefilled Syringes Segment Holds the largest Market Share in Material Type

In terms of material, the prefilled syringes market is segmented into glass and plastic. Between these two segments, the glass prefilled syringes segment held the largest market share in 2020. Glass is the first choice for prefilled syringe manufacturers because of its superior barrier capabilities and regulatory ease. Moreover, the segment is also witnessing a huge demand due to the significant benefits associated with it, such as interoperability with a variety of filling machines, preventing air and water vapor from reacting with drug components, and mooth integration into pharmaceutical companies' PFS processes.

Single-Chamber Prefilled Syringes dominates the Market in Design Segment

Based on the design, the global prefilled syringes market is segmented into single-chamber, dual-chamber and customized. Due to the significant advantage associated with the usage of single-chamber prefilled syringes over vials, the single-chamber prefilled syringes segment held the biggest share in the prefilled syringes market in 2020. Optimized Active Pharmaceutical Ingredient (API) file in prefilled syringes, for example, allows for exact administration of the required dose. Only a traceable quantity of API remains in the needle of a prefilled syringe after injection. Besides this, rise in adoption of self-managing parenteral drugs due to the prevalence of chronic diseases and ease offered by single-chamber prefilled syringes is positively impacting the segment growth.

Europe Holds the Largest Share in the Global Prefilled Syringes Market

Based on region, the global prefilled syringes market can be grouped into North America, Europe, the Asia-Pacific, Latin America and the Middle East & Africa. Among these regions, Europe with its growing biologics and biosimilars industry, increased prevalence of chronic diseases, technological improvements, global expansion by top manufacturers, aging population, and high adoption of self-injection devices, held the highest market share in 2020. Nevertheless. due to the rising frequency of chronic diseases and a rapidly growing patient population, Asia-Pacific is also catching up as the fastest-growing market.

Impact of COVID-19 Outbreak

The global prefilled syringes business was severely impacted by the COVID-19 epidemic, as medicine manufacturing and supply chains were hindered due to a nationwide lockdown imposed by the government of different countries to curb the spread of the deadly virus. In order to limit the virus, the major manufacturing countries in the Americas, Europe, and the Asia Pacific imposed a complete border closure; consequently, import, export, and distribution of prefilled syinges were highly affected. Nevertheless, the pandemic resulted in an unexpected growth in the pharmaceutical sector as a result of a shift in focus toward enhanced drug delivery methods for disease treatment, which has positively benefited the market for prefilled syringes.

Some of the leading market players in the global prefilled syringes market are Gerresheimer AG, Schott AG, Becton, Dickinson and Company, West Pharmaceutical Services, Inc., Vetter Pharma International Gmbh, Weigao Group, Ompi (A Stevanato Group Company), Catalent, Inc., Nipro Corporation, Baxter International Inc., Elcam Medical, Ypsomed, Oval Medical Technologies Ltd., Shl Medical Ag, Terumo Corporation, Medtronic Plc, Gerresheimer, Abbott, Nipro Medical Corporation, and other prominent players.

The global market for prefilled syringes is highly consolidated. In order to gain a substantial position in the prefilled syringes market, industry players have been consistently engaging in numerous partnerships and collaborations

Don't miss the business opportunity of the global prefilled syringes market. Consult our analysts to gain crucial insights and facilitate your business growth.

The in-depth analysis of the report provides information about growth potential, upcoming trends, and statistics of global prefilled syringes market size & forecast. The report promises to provide recent technology trends of the global prefilled syringes market and industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyses the growth drivers, challenges, and competitive dynamics of the market.

About Us

BlueWeave Consulting provides comprehensive Market Intelligence (MI) Solutions to businesses regarding various products and services online & offline. We offer all-inclusive market research reports by analysing both qualitative and quantitative data to boost up the performance of your business solutions. BWC has built its reputation from the scratches by delivering quality inputs and nourishing long-lasting relationships with its clients. We are one of the promising digital MI solutions companies providing agile assistance to make your business endeavours successful.

0 notes

clevertimetravelpaper · 2 years ago

Text

Europe Vaccine Delivery Devices Market SWOT Analysis, Key Players, Business, Regional Analysis, Research Analysis, Growth, Trends, Share and Forecast

The European Vaccine Delivery Devices Market is expected to experience market growth during the forecast period from 2020 to 2027. Data Bridge Market Research analyzes that the market is growing with a CAGR of 7.5% during the period forecast from 2020 to 2027 and is expected to reach USD 1,301.25 million by 2027 from USD 735.63 million in 2019. Development of new vaccines and increased government support and investment are the main drivers driving propelled the market demand during the forecast period.

Vaccine Delivery Devices includes features such as new vaccine development and will impact manufacturers new product launch in the market which increases its demand as well as growing infectious disease burden which drives the demand for precise delivery of vaccines to elicit a strong immune response upon delivery of targeted vaccines.

Get Sample PDF of the Report – https://www.databridgemarketresearch.com/request-a-sample/?dbmr=europe-vaccine-administration-devices-market

The Vaccine Delivery Devices Market report provides details about market share, new developments and product pipeline analysis, impact of national and localized market players, analyzes opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand Vaccine Delivery Devices market analysis and scenario, contact Data Bridge Market Research for Analyst Brief, our team will help you create revenue impact solution to achieve your desired objective .

Europe Vaccine Delivery Devices Market Scope and Size

The vaccine delivery devices market is segmented on the basis of product, administration route, type, brand, dosage, vaccine type, modality, ease of use, of the end user and the distribution channel. Growth between segments helps you analyze growth niches and strategies to approach the market and determine your main areas of application and the difference between your target markets.

On the basis of product, the vaccine delivery devices market is segmented into syringes , auto injectors, jet injectors, micro needles, inhalation/pulmonary delivery, micro injection system, pen injection devices, biodegradable implants, needle-free injection systems based on electroporation, oral systems/sublingual vaccine delivery systems, self-learning devices and other devices. In 2020, the syringe segment is expected to dominate the vaccine delivery device market as syringes are mainly used in different vaccine delivery facilities by healthcare professionals.

Based on route of administration, the vaccine delivery devices market is segmented into intramuscular, subcutaneous, and intradermal. In 2020, the intramuscular segment is expected to dominate the vaccine delivery devices market as it is the most chosen vaccine delivery procedure among vaccine deliverers.

On the basis of type, the vaccine delivery devices market is segmented into marketed vaccines and clinical-stage (electroporation) vaccines. In 2020, commercialized vaccines are expected to dominate the vaccine delivery devices market as auto-injectors, jet injectors, syringes, microinjections, among others are various types of vaccine delivery devices available on the market.

On the basis of brand, the vaccine delivery device market is segmented into BD accuspray nasal spray system, BD hypak for vaccines glass prefillable syringe system, BD uniject self-disabling prefillable injection system, Gx InnoSafe, Gx RTF clearject, plajex, and others. In 2020, other segments are expected to dominate the vaccine delivery devices market owing to the presence of a wide variety of vaccine delivery devices and their use in determining accurate COVID vaccine doses -19 in effect.

On the basis of dosage, the vaccine delivery devices market is segmented into fixed and variable . In 2020, the fixed segment is expected to dominate the vaccine delivery devices market as the defined volume of vaccine administered in order to produce an effective immune response.

On the basis of vaccine type, the vaccine delivery devices market is segmented into bivalent oral poliovacine, BCG vaccine, tetanus-diphtheria vaccine, DTP-HEPB-HIB vaccine, influenza vaccine, pneumococcal conjugate vaccine, measles and others. In 2020, the bivalent oral polio vaccines segment dominates the vaccine delivery devices market owing to the growing prevalence of poliomyelitis and growing demand for improved mucosal vaccine delivery systems.

On the basis of modality, the vaccine delivery device market is segmented into automatic vaccine delivery device and manual vaccine delivery device. In 2020, the automatic vaccine delivery device segment is dominating the vaccine delivery device market as automatic injectors, among other devices, can easily be handled at home, reducing the need for a vaccine administrator specified.

On the basis of user-friendliness, the vaccine delivery device market is segmented into disposable and reusable. In 2020, the disposable segment dominates the vaccine delivery device market as technologically advanced syringes such as self-disposable syringes are widely used for vaccine delivery. In addition, disposable vaccine delivery devices overcome the risks of infection transfer.

On the basis of end-user, the vaccine delivery devices market is segmented into hospitals , community centers, home care facilities, research and academic institutes, outpatient surgery center and others. In 2020, hospital segment is dominating the vaccine delivery devices market as maximum number of people visit hospitals in order to get accurate vaccine dosage.

On the basis of distribution channel, the vaccine delivery devices market is segmented into direct tenders, retail and others. In 2020, the direct tender segment is dominating the vaccine delivery devices market as it is the major source of supply of vaccine delivery devices by hospitals, clinics, community centers, among others .

To get more insights into the market analysis, browse the research report summary @- https://www.databridgemarketresearch.com/reports/europe-vaccine-administration-devices-market

Country Level Analysis of Vaccine Delivery Devices Market

The Vaccine Delivery Devices market is analyzed and market size information is provided on the basis of country, product, route of administration, type, brand, dosage, type of vaccine, modality, ease of use, end user and distribution channel. The countries covered in the Vaccine Delivery Devices market report are Germany, UK, France, Italy, Spain, Switzerland, Netherlands, Belgium, Russia , Turkey and the rest of Europe.

Germany dominates the European market owing to the growing demand for vaccine delivery devices for the stationary vaccine delivery device segment. The country section of the report also provides impact factors on the Individual Vaccine Delivery Devices market and regulatory changes in the national market that have an impact on current and future market trends. Data points such as new sales, replacement sales, country demographics, regulatory acts, and import-export tariffs are some of the major indicators used to forecast the market scenario for each country.In addition, the presence and availability of global brands and the challenges they face due to significant or rare competition from local and national brands, the impact of sales channels are considered while providing a forecast analysis of national data.

Competitive Landscape and Vaccine Delivery Devices Market Share Analysis

Vaccine Delivery Devices market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, research and development investment, new market initiatives, production sites and facilities , company strengths and weaknesses, product launch, product testing pipelines, product approvals, patents, product breadth and scope, application dominance, technology lifeline curve . The data points provided above are only related to the company's focus on the vaccine delivery device market.

The main companies selling vaccine delivery devices are BD, Gerresheimer AG, Corium Inc., iHealthNet LLC, Enesi, SCHOTT AG (a subsidiary of Carl-Zeiss-Stiftung), 3M, Terumo Europe NV (a subsidiary of Terumo Corporation ), West Pharmaceutical Services, Inc., Bespak Europe Ltd., Antares Pharma, among other domestic and global players. Several product launches and agreements are also initiated by the companies across the globe which are also accelerating the vaccine delivery devices market.

Browse Complete TOC at- https://www.databridgemarketresearch.com/toc/?dbmr=europe-vaccine-administration-devices-market

Top Healthcare Reports

North America Healthcare BPO Market - Industry Size, Shares, Trends and Growth Prospects https://www.databridgemarketresearch.com/reports/north-america-healthcare-bpo-market

Prefilled Syringes Market - Industry Size, Shares, Trends and Growth Prospects https://www.databridgemarketresearch.com/reports/global-prefilled-syringes-market

Europe Prefilled Syringes Market - Industry Trends and Forecast to 2028 https://www.databridgemarketresearch.com/reports/europe-prefilled-syringes-market

Asia Pacific Prefilled Syringes Market - Industry Size, Shares, Trends and Growth Prospects https://www.databridgemarketresearch.com/reports/asia-pacific-prefilled-syringes-market

Dual Chamber Prefilled Syringes Market - Industry Size, Shares, Trends and Growth Prospects https://www.databridgemarketresearch.com/reports/global-dual-chamber-prefilled-syringes-market

Anesthesia and Respiratory Devices Market - Industry Size, Shares, Trends and Growth Prospects https://www.databridgemarketresearch.com/reports/global-anesthesia-and-respiratory-devices-market

Europe Anesthesia and Respiratory Devices Market - Industry Size, Shares, Trends and Growth Prospects https://www.databridgemarketresearch.com/reports/europe-anesthesia-and-respiratory-devices-market

About Data Bridge Market Research:

One absolute way to predict what the future holds is to understand today's trend! Data Bridge Market Research presented itself as an unconventional and neoteric market research and consulting company with an unparalleled level of resilience and integrated approaches. We are committed to unearthing the best market opportunities and fostering effective information for your business to thrive in the market. Data Bridge strives to provide appropriate solutions to complex business challenges and initiates an effortless decision-making process. Data Bridge is a suite of pure wisdom and experience that was formulated and framed in 2015 in Pune.

Data Bridge Market Research has over 500 analysts working across different industries. We have served over 40% of Fortune 500 companies globally and have a network of over 5,000 clients worldwide. Data Bridge knows how to create satisfied customers who rely on our services and rely on our hard work with certainty. We are pleased with our glorious 99.9% customer satisfaction rating.

Data Bridge Market Research

USA: +1 888 387 2818

UK: +44 208 089 1725

Hong-Kong : +852 8192 7475

E-mail :- [email protected]

0 notes

blueweave · 4 years ago

Text

Global Prefilled Syringes Market Exhibiting Prolific Growth: Predicted to Garner USD 9.40 Billion During the Forecast Period (2021- 2027)

Advancements in prefilled syringes technology Driving the Growth of Prefilled Syringes Market

Scarcity of prefilled syringes with integrated safety features hampering market growth

Safety Prefilled Syringes Segment is the largest Type Segment

Request to Download Free Sample Report @ https://www.blueweaveconsulting.com/pre-filled-syringes-market-report/report-sample

Glass Prefilled Syringes Segment Holds the largest Market Share in Material Type

Single-Chamber Prefilled Syringes dominates the Market in Design Segment

Europe Holds the Largest Share in the Global Prefilled Syringes Market

Impact of COVID-19 Outbreak

Don't miss the business opportunity of the global prefilled syringes market. Consult our analysts to gain crucial insights and facilitate your business growth.

About Us

BlueWeave Consulting Pvt Ltd

+1 866 658 6826 | +1 425 320 4776 | +44 1865 60 0662

[email protected]

https://www.linkedin.com/company/blueweaveconsulting/

#Prefilled Syringes Market #Prefilled Syringes Market Size #Prefilled Syringes Market Share #Prefilled Syringes Market Forecast #Prefilled Syringes Market Trend #Prefilled Syringes Market Report

0 notes

rahulmmr · 4 years ago

Text

Global Needles Market was valued US$6.27 Bn in 2019 and is expected to reach US$XX Bn by 2026, at a CAGR of XX % during a forecast period.

The report includes the analysis of impact of COVID-19 lock-down on the revenue of market leaders, followers, and disrupters. Since lock down was implemented differently in different regions and countries, impact of same is also different by regions and segments. The report has covered the current short term and long term impact on the market, same will help decision makers to prepare the outline for short term and long term strategies for companies by region.

The major driving factors of the global needles market are increasing the adoption of injectable drugs, rising demand for injection, increasing medical costs, and growing demand for hormone supplements. Moreover, the growing demand for point-of-care diagnostic products also propels the demand for needles across the globe.

Furthermore, owing to the benefits of injectable drugs over tablet formulations, companies are focusing on the development of injectable drug delivery systems, including syringes and needles. Various pharmaceutical and biotechnology companies are continuously involved in the development of effective and novel injectable drugs for the treatment of chronic diseases, which is boosting the growth of the global needles market. Rising demand for self-injectable and use of safety needles are created opportunities for the players in the needles industry. Self-injectable are highly useful in emergency conditions, such as allergies; and chronic diseases, like diabetes and rheumatoid arthritis.

However, high risks of infections associated with the administration of drug delivery by needles obstruct the growth of the global needles market. In addition, increased risk of needlestick injuries and the availability of alternatives also hampers the growth of the global needles market. The report contains a detailed list of factors that will drive and restrain the growth of the glass recycling market.

Based on type, the conventional needles market is estimated to command the larger share of the global needles market due to growing demand for biosimilar products, the increasing incidence of chronic disease and the expanding injectable market are the key factors contributing to the growth of the conventional needles market segment.

By product, the blood collection needles segment is expected to grow at a significant CAGR during the forecast period due to the increasing number of blood donations and technological advancements in blood collection sets are driving the growth of the blood collection needles market segment.

In terms of delivery mode hypodermic needles segment is expected to account for the largest share of the needles market owing to the needles are used for injecting the drug into the subcutaneous layer, this enables the quick absorption of active compounds into the bloodstream, which is a key factor contributing to the market growth of delivery mode market segment.

North America held the largest share of the global needles market, followed by Europe due to the rising incidence of chronic diseases, initiatives by different organizations for the reduction in blood-borne infections, and increasing prevalence of cardiovascular diseases.

In Aug 2017, Ethicon US, LLC, has launched PROXISURE, an advanced laparoscopy suturing device which will upsurge the accuracy for minimally invasive surgery which will allow the surgeons to perform the surgery in an active manner by reaching the control bites, desired angles, and secure knots.

The objective of the report is to present a comprehensive analysis of the Global Needles Market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that includes market leaders, followers and new entrants by region. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors by region on the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers.

The report also helps in understanding Global Needles Market dynamics, structure by analyzing the market segments and project the Global Needles Market size. Clear representation of competitive analysis of key players by type, price, financial position, product portfolio, growth strategies, and regional presence in the Global Needles Market make the report investor’s guide.

visit at-https://www.maximizemarketresearch.com/market-report/global-needles-market/20121/

Scope of Global Needles Market:

Global Needles Market by Type:

• Conventional Needles

• Bevel Needles

• Blunt Fill Needles

• Filter Needles

• Vented Needles

• Safety Needles

• Active needles

• Passive Needles

Global Needles Market by Product Type:

• Suture Needles

• Blood Collection Needles

• Ophthalmic Needles

• Dental Needles

• Insufflation Needles

• Pen Needles

• Other Needles

Global Needles Market by Delivery Mode:

• Hypodermic Needles

• Intravenous Needles

• Intramuscular Needles

• Intraperitoneal Needles

Global Needles Market by Material:

• Stainless Steel Needles

• Plastic Needles

• Glass Needles

• PEEK Needles

Global Needles Market by End-User:

• Hospitals & Clinics

• Diagnostic Centers

• Home Healthcare

• Others

Global Needles Market by Region:

• North America

• Europe

• Middle East & Africa

• Asia Pacific

• Latin America

Key players operating in Global Needles Market:

• Becton

• Dickinson & Company

• Medtronic plc

• Hamilton Company

• Stryker Corporation

• Terumo Corporation

• B. Braun Melsungen AG

• Boston Scientific Corporation

• Nipro Medical Corporation

• Novo Nordisk A/s

• Thermo Fisher Scientific

• Smiths Medical

About Us:

Maximize Market Research provides B2B and B2C market research on

20,000 high growth emerging technologies & opportunities in Chemical,

Healthcare, Pharmaceuticals, Electronics & Communications, Internet of

Things, Food and Beverages, Aerospace and Defense and other

manufacturing sectors.

#Needles Market

0 notes

marketreports-world · 3 years ago

Text

Injectable Drug Delivery Devices Market - Global Forecast Till 2027

Global Injectable Drug Delivery Devices Market Research Report: Information by Devices (Conventional Injection Devices and Self-Injection Devices), Therapeutic Application (Autoimmune Diseases, Hormonal Disorders and Cancer), Usage Pattern (Curative pattern and Immunization), Site of Delivery (Intramuscular, Subcutaneous and Intra Dermal), Distribution Channel (Hospital & Retail Pharmacies and Online Platforms), Facility of Use (Hospitals and Clinics and Home Care Settings) and Region (Americas, Europe, Asia-Pacific and Middle East & Africa) - Forecast till 2027

Injectable drug delivery devices are used in administrating the medication into the circulatory system. It is the most effective way to ensure a quick response. These devices are commonly used when a patient is unconscious and needs urgent medical assistance. Injectable drugs are majorly used during treatments of chronic diseases like cancer and diabetes.

Over the past few years, the injectable drug delivery devices market is growing rapidly. Increasing cancer cases is the major driving force pushing up the market growth. Furthermore, the increasing occurrence of needle-stick injuries, rising prevalence of chronic diseases, and increasing uses of biologics such as factors are escalating the market on the global platform.

Acknowledging the increasing market size of the market, Market Research Future (MRFR) in its recently published study report asserts that the global injectable drug delivery devices market will garner exponential accruals registering 11.8% CAGR during the review period (2017 – 2023).

Additional factors positively impacting the market growth include technological advancements, improving outcomes and patients’ experience, beneficial reimbursement policies, and increasing awareness towards healthcare.

On the other hand, factors such as the safety concerns regarding the use of injectable, risk of blood-borne infections, and the introduction of the alternative drug delivery devices are expected to impede the market growth of these devices.

Global Injectable Drug Delivery Devices Market – Segmentations

MRFR has segmented its analysis into four Key dynamics for an easy grasp; By Types : Devices (self-injection devices and conventional injection devices) and Formulations (conventional drug delivery, novel drug delivery, and others.) By Applications : Immune Disorder, Cancer, and Diabetes among others. By End-Users : Hospitals, Homecare, and Clinics among others.

By Regions : North America, Europe, APAC and the Rest-of-the-World.

Request Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/1211

Global Injectable Drug Delivery Devices Market – Geographical Analysis

The North American region accounts for the leading market for injectable drug delivery devices, capturing a significant market share, followed by Europe and the Asia Pacific, respectively. North America is a well-developed region with the highest GDP, worldwide, which helps the region to have the edge over other regions in terms of every aspect including healthcare and technology. Factors such as the huge patient pool suffering from chronic diseases such as diabetes and cancer, the presence of geriatric population and development in medical technology are supporting the growth of the market.

Certainly, the high economic growth is a key force driving the market growth in the region, allowing access to the quality of life for the people. The US, backed by the high per capita healthcare expenditures, contributes to the growth of the regional market, significantly. Owing to the augmenting demand for the injectable drug delivery devices, the region is projected to create a larger revenue pocket in the global market by 2023.

The European region stands the second-largest position in the global injectable drug delivery devices market. The resurging economy is playing a vital role in the market development, allowing the proliferation of the healthcare sector in the region. The well-established healthcare sector is a key driving force contributing to the market growth in the region.

Germany, heading with its flourishing medical devices markets, hugely contributes to the growth of the regional market. Furthermore, the U.K. and France with the increasing investment in injectable drug delivery devices drive the regional market at a large scale. The Europe injectable drug delivery devices market is estimated to register a phenomenal CAGR during the review period.

Injectable drug delivery devices market in the Asia Pacific region is growing rapidly owing to the huge patient population and the rising economy in countries such as China, Japan, South Korea, and India. Furthermore, factors such as the rising demand for quality devices in healthcare and rapidly developing healthcare technology is expected to lead the market growth in the APAC region.

Global Injectable Drug Delivery Devices Market – Competitive Landscape

The global Injectable Drug Delivery Devices market appears to be fiercely competitive and fragmented with many well-established players having the global presence. Brand reinforcement, mergers & acquisitions, and innovation remain the popular trends for the key players in the market.

Key Players:

Some of the eminent leaders of the market include Baxter International (US), Becton, Dickinson and Company (US), Schott AG (Germany), Pfizer (US), Eli Lilly and Company (US), Gerresheimer AG (Germany), Antares Pharma, Inc. (US), Terumo Corporation (Japan), Novo Nordik (Denmark), Unilife Corporation (US), Sanofi SA (France), Zogenix, Inc (US), Presage Bioscience (US), Hospira, Inc (US), MicroCHIPS, Inc (US), Genentech Inc. (US), Pearl Therapeutics Inc (US), and Bend Research (US).

Industry/ Innovation/ Related News:

October 08, 2018 - West Pharmaceutical Services, Inc. (US), one of the leading global players in innovative solutions for injectable drug administration, announced a new Integrated Solutions Program to help to reduce risk and mitigate regulatory complexity. The programme is designed highlighting West’s industry expertise through a number of technical- and regulatory-focused PDA presentations through.

The programme will thus help its pharmaceutical partners at the PDA Universe of Prefilled Syringes and Injection Devices and CPHL Worldwide conferences with the simplified process to bring their devices to the market.

October 22, 2018 - Inolife R&D Inc. (Canada), an emerging life science company and innovation leader in comprehensive needle-free injectable solutions announced its partnership with Empower Clinics Inc. (US), a leading operator of medical cannabis and wellness clinics for the national distribution agreement within the United States. As per the terms in the contract, Empower Clinics will make Inolife’s needle-free injection solutions available to patients at their clinics in Oregon, Washington, and Illinois.

Browse Detailed TOC with COVID-19 Impact Analysis at: https://www.marketresearchfuture.com/reports/injectable-drug-delivery-devices-market-1211

About Market Research Future:

Related Report:

Global Acute Pancreatitis Market Research Report—Forecast till 2025

Contact:

Akash Anand

Market Research Future

+1 646 845 9312

Email: [email protected]

#Injectable Drug Delivery Devices

0 notes